A double-blind, placebo-controlled, dose-escalation trial of pimavanserin in Parkinson's disease and psychosis

被引：0
|
作者：
Revell, Stephen
Friedman, Joseph
Mills, Roger G.
Williams, Hilde
Johnson, Ann D.
Bahr, Daun
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A284 / A285
页数：2
相关论文
共 50 条
  • [41] Pingchan granule for depressive symptoms in parkinson's disease:A randomized, double-blind, placebo-controlled trial
    Si-chun Gu
    Jie Zhou
    Qing Ye
    Can-xing Yuan
    Journal of Integrative Medicine, 2021, 19 (02) : 120 - 128
  • [42] Transdermal Rotigotine in Early Stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Trial
    Mizuno, Yoshikuni
    Nomoto, Masahiro
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2013, 28 (10) : 1447 - 1450
  • [43] Velnacrine for the treatment of Alzheimer's disease: A double-blind, placebo-controlled trial
    Zemlan, FP
    Folks, DG
    Goldstein, BJ
    Gottlieb, G
    Holub, RF
    Linden, RD
    Margolin, RA
    Richter, RW
    Speakman, WF
    Strub, RL
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) : 1105 - 1116
  • [44] A double-blind, placebo-controlled trial of diclofenac misoprostol in Alzheimer's disease
    Scharf, S
    Mander, A
    Ugoni, A
    Vajda, F
    Christophidis, N
    NEUROLOGY, 1999, 53 (01) : 197 - 201
  • [45] A Randomized, Double-Blind, Placebo-Controlled Trial of Pridopidine in Huntington's Disease
    Kieburtz, Karl
    McGarry, Andrew
    McDermott, Michael
    Kayson, Elise
    Harrison, Madaline
    Marder, Karen
    Walker, Francis
    MOVEMENT DISORDERS, 2013, 28 (10) : 1407 - 1415
  • [46] A double-blind, randomised, placebo controlled, dose-escalation study of remacemide in patients with acute stroke
    Dyker, AG
    Muir, KW
    Lees, KR
    STROKE, 1997, 28 (01) : 5 - 5
  • [47] A double-blind placebo-controlled study of the efficacy of a single dose of subcutaneous apomorphine in advanced Parkinson's disease
    Koller, W
    NEUROLOGY, 2004, 62 (07) : A329 - A329
  • [48] Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study
    Ballard, Clive
    Banister, Carol
    Khan, Zunera
    Cummings, Jeffrey
    Demos, George
    Coate, Bruce
    Youakim, James M.
    Owen, Randall
    Stankovic, Srdjan
    LANCET NEUROLOGY, 2018, 17 (03): : 213 - 222
  • [49] Double-blind, placebo-controlled trials for surgical interventions in Parkinson disease
    Olanow, CW
    ARCHIVES OF NEUROLOGY, 2005, 62 (09) : 1343 - 1344
  • [50] Efficacy of double-blind, placebo-controlled pramipexole against depression in Parkinson's disease
    Barone, P.
    Poewe, W.
    Tolosa, E.
    Rascol, O.
    Massey, D.
    Debieuvre, C.
    Albrecht, S.
    MOVEMENT DISORDERS, 2009, 24 : S347 - S347
12345